Copertina

Feasibility of assessing cognitive impairment via distributed camera network and privacy‐preserving edge computing

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Chaitra Hegde, Yashar Kiarashi, Allan I. Levey, Amy D. Rodriguez, Hyeokhyen Kwon, Gari D. Clifford
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Feasibility of assessing cognitive impairment via distributed camera network and privacy-preserving edge computing
di: Hegde, Chaitra, et al.
Pubblicazione: (2024)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
di: Marieclaire Overton, et al.
Pubblicazione: (2025)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
di: Carla R. Schubert, et al.
Pubblicazione: (2024)

The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
di: Craig Ritchie, et al.
Pubblicazione: (2025)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
di: Zheng Long Lee, et al.
Pubblicazione: (2026)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
di: Russell Banks, et al.
Pubblicazione: (2024)

Cognitive dispersion is related to subtle objective daily functioning changes in older adults with and without cognitive impairment
di: Alyssa N. De Vito, et al.
Pubblicazione: (2024)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
di: Julius Opwonya, et al.
Pubblicazione: (2024)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
di: Elyse Couch, et al.
Pubblicazione: (2025)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
di: Samuel L. Warren, et al.
Pubblicazione: (2026)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
di: Simone Salemme, et al.
Pubblicazione: (2025)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
di: Sebastiaan De Keersmaecker, et al.
Pubblicazione: (2024)

Artificial intelligence detection of cognitive impairment in older adults during walking
di: Shuichi P. Obuchi, et al.
Pubblicazione: (2024)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
di: Kay Jann, et al.
Pubblicazione: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
di: Kevin Duff, et al.
Pubblicazione: (2024)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Pubblicazione: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
di: Gang Li, et al.
Pubblicazione: (2025)

Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
di: Hankyung Jun, et al.
Pubblicazione: (2026)

P‐tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study
di: Samantha C. Burnham, et al.
Pubblicazione: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
di: Miguel Ángel Rivas‐Fernández, et al.
Pubblicazione: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
di: Ihab Hajjar, et al.
Pubblicazione: (2024)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
di: Jacqueline Chua, et al.
Pubblicazione: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
di: Sunu Mathew, et al.
Pubblicazione: (2025)

Human and large language model judgments of cognitive impairment from language: An explainable artificial intelligence approach
di: Maya Zadok, et al.
Pubblicazione: (2026)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
di: Rachel R. Jin, et al.
Pubblicazione: (2025)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
di: Gustavo Luis Verón, et al.
Pubblicazione: (2025)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
di: Adam H. Dyer, et al.
Pubblicazione: (2025)

Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD
di: Cellas A. Hayes, et al.
Pubblicazione: (2026)

Mild behavioral impairment and its relationship to cognition in community‐dwelling older adults from the Boston Latino Aging Study
di: Jorge Alcina, et al.
Pubblicazione: (2025)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
di: Joyce R. Chong, et al.
Pubblicazione: (2024)

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
di: Luwen Cao, et al.
Pubblicazione: (2024)

ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes
di: Luciana Mascarenhas Fonseca, et al.
Pubblicazione: (2024)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
di: Jessie T. Yan, et al.
Pubblicazione: (2025)

Comparing retrospective informant assessments to prospectively collected cognitive measures in the Health and Retirement Study
di: Ali G. Hamedani, et al.
Pubblicazione: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
di: María A. Rodríguez‐Santiago, et al.
Pubblicazione: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
di: Juliana N. Souza‐Talarico, et al.
Pubblicazione: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
di: Paul C. Donaghy, et al.
Pubblicazione: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
di: Felix Dörr, et al.
Pubblicazione: (2025)

Culturally adapted cognitive assessment tool for Indigenous communities in Brazil: Content, construct, and criterion validity
di: Camila Carlos Bezerra, et al.
Pubblicazione: (2024)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
di: Yuhan Xie, et al.
Pubblicazione: (2025)